Pub Date : 2023-04-27DOI: 10.1108/tcj-06-2021-0089
Huining Jia, J. Jin, B. Lindsay
Research methodology This paper uses financial report information to analyze the accounting results of the COVID-19 vaccine development for Johnson & Johnson (J&J). This paper also uses stock price information to analyze the market reactions to the COVID-19 vaccine development and the state of clinical trials for J&J.